Repare Therapeutics Inc Capital Reinvestment Ratio
Repare Therapeutics Inc capital reinvestment ratio. Repare Therapeutics Inc (RPTX) has a Capital Reinvestment Ratio of 0.00x as of September 2022, meaning it reinvests 0% of its operating cash flow ($88.16 Million) in capital expenditures ($266.00K). Check RPTX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Repare Therapeutics Inc (2022–2022)
Capital reinvestment ratio of Repare Therapeutics Inc from 2022 to 2022. This chart tracks Repare Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore Repare Therapeutics Inc (RPTX) equity growth momentum to track the company's year-over-year net asset growth rate.
Repare Therapeutics Inc Capital Reinvestment Ratio by Year (2022–2022)
Repare Therapeutics Inc capital reinvestment ratio by year from 2022 to 2022. For the full cash flow conversion analysis, see cash efficiency ratio of Repare Therapeutics Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 1.87x | $322.00K | $602.00K | — |